Malak Yahia Qattan

DR.  Malak Yahia Qattan
Assistant professor in Leukemia and stem cell research
College of Applied Studies and Community Service
Department of Medical Sciences
King Saud University
Olishah Campus, Building 4, Office # 22
Riyadh, Saudi Arabia
mqattan@ksu.edu.sa
Biography
I took up my position as a vice director of health sciences department in college of applied medical science and community Service in King Saud University in November 2014. Prior to this I completed my PhD in Leukemia and stem cell research, molecular endocrinology at the University of Manchester, UK. I was a Lecturer in college of applied medical science and community Service in King Saud University from 2007 to 2009. 
Teaching
I am involved in the teaching of Medical Secretary Diploma subject which is Medical terminology for establish the medical terms of the first level student.  From 2007 to 2009 I designed and delivered of the teaching of a variety of modules in course curriculum for Clinical Laboratory courses in particular, Hematology, Blood Banking, Bacteriology 1, Bacteriology 2, Immunology and Epidemiology. Furthermore I have devised the final year problem for BSc molecular biology students in University of Manchester in school of life science.
Research Interests
My research focuses on the investigation of mechanisms of gene regulation and cancer biology. Research investigates molecular basis of cellular response to hormonal and stress signals, with the aim to analyse gene expression profiles in leukemia associated with drug resistance. My long term interests are in investigating the mechanisms by which clinically relevant drugs mediate their therapeutic effects in order to improve available treatments and to develop novel pharmacologically beneficial approaches. We also study effects of DNA damage on tumor suppressor p53 that is a gene mutated in over half of human cancers. The deregulation of DNA damage inducible signalling pathways plays a major role in the development of cancer and analysis of components of these pathways is vital for the diagnosis, prognosis and therapy of malignant tumours.
Overall my observations provide detailed insight in the molecular networks governing cellular survival in numerous physiological and pathological processes. This knowledge can find application in the pharmaceutical industry, has been highly cited and internationally recognized. Several collaborative projects with clinical partners are ongoing in order to translate this knowledge to clinic and to pursue goals of personalized medicine to generate an efficient roadmap that will lead rapidly and safely to effective individual treatment that will eliminate diseases and create better health care for all.
 
 Qualifications

Publications
Qattan M, Demonacos C,Krstic-Demonacos M. (2012). Roadmap to personalised medicine. Croatian Medical Journal, 53, 4. eScholarID:179195 | DOI:10.3325/cmj.2012.53.294